These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 11263170

  • 21. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
    Santillan A, Karam AK, Li AJ, Giuntoli R, Gardner GJ, Cass I, Karlan BY, Bristow RE.
    Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
    [Abstract] [Full Text] [Related]

  • 22. [Studies of second-look operations (SLO) in ovarian cancer].
    Yuzawa H.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1310-6. PubMed ID: 2658822
    [Abstract] [Full Text] [Related]

  • 23. Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy.
    Landoni F, Pellegrino A, Cormio G, Milani R, Maggioni A, Mangioni C.
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):233-7. PubMed ID: 9512334
    [Abstract] [Full Text] [Related]

  • 24. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D, Fountzilas G, Aravantinos G, Kalofonos C, Efstathiou H, Farmakis D, Skarlos D, Pavlidis N, Economopoulos T, Dimopoulos MA.
    Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
    [Abstract] [Full Text] [Related]

  • 25. Recurrent micropapillary serous ovarian carcinoma.
    Bristow RE, Gossett DR, Shook DR, Zahurak ML, Tomacruz RS, Armstrong DK, Montz FJ.
    Cancer; 2002 Aug 15; 95(4):791-800. PubMed ID: 12209723
    [Abstract] [Full Text] [Related]

  • 26. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
    Harter P, du Bois A, Hahmann M, Hasenburg A, Burges A, Loibl S, Gropp M, Huober J, Fink D, Schröder W, Muenstedt K, Schmalfeldt B, Emons G, Pfisterer J, Wollschlaeger K, Meerpohl HG, Breitbach GP, Tanner B, Sehouli J, Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Committee, AGO Ovarian Cancer Study Group.
    Ann Surg Oncol; 2006 Dec 15; 13(12):1702-10. PubMed ID: 17009163
    [Abstract] [Full Text] [Related]

  • 27. [Clinical analysis of prognostic factors for stage III ovarian epithelial carcinoma].
    Wu M, Shen K, Lang JH, Huang RL, Huang HF, Pan LY.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 01; 85(20):1406-9. PubMed ID: 16029654
    [Abstract] [Full Text] [Related]

  • 28. [Analysis of risk factors for epithelial ovarian cancer recurrence].
    Liu S, Liu JH, Huang H, Peng XP, Wang YM.
    Ai Zheng; 2003 Nov 01; 22(11):1197-200. PubMed ID: 14613652
    [Abstract] [Full Text] [Related]

  • 29. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer.
    Munkarah AR, Coleman RL.
    Gynecol Oncol; 2004 Nov 01; 95(2):273-80. PubMed ID: 15491746
    [Abstract] [Full Text] [Related]

  • 30. [Secondary cytoreductions in the treatment of ovarian cancers].
    Zylberberg B, Dormont D, Janklewicz S, Daraï E, Madelenat P, Antoine JM.
    Gynecol Obstet Fertil; 2000 Feb 01; 28(2):127-36. PubMed ID: 10758587
    [Abstract] [Full Text] [Related]

  • 31. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG, Gershenson DM, Malpica A, Deavers M.
    Am J Surg Pathol; 2006 Nov 01; 30(11):1367-71. PubMed ID: 17063075
    [Abstract] [Full Text] [Related]

  • 32. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
    Everett EN, French AE, Stone RL, Pastore LM, Jazaeri AA, Andersen WA, Taylor PT.
    Am J Obstet Gynecol; 2006 Aug 01; 195(2):568-74; discussion 574-6. PubMed ID: 16890558
    [Abstract] [Full Text] [Related]

  • 33. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer].
    Li M, Huang X.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct 01; 31(10):621-3. PubMed ID: 9275460
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
    Tebes SJ, Sayer RA, Palmer JM, Tebes CC, Martino MA, Hoffman MS.
    Gynecol Oncol; 2007 Sep 01; 106(3):482-7. PubMed ID: 17590420
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer.
    Benedetti Panici P, De Vivo A, Bellati F, Manci N, Perniola G, Basile S, Muzii L, Angioli R.
    Ann Surg Oncol; 2007 Mar 01; 14(3):1136-42. PubMed ID: 17195909
    [Abstract] [Full Text] [Related]

  • 40. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma.
    Helm CW, Randall-Whitis L, Martin RS, Metzinger DS, Gordinier ME, Parker LP, Edwards RP.
    Gynecol Oncol; 2007 Apr 01; 105(1):90-6. PubMed ID: 17173957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.